Combination Of Hyperopic Lasik And Pharmacological Treatment Of Presbyopia
Published 2022 - 40th Congress of the ESCRS
Reference: FPT03.12 | Type: Free paper | DOI: 10.82333/x9y5-jd26
Authors: Giovanna Benozzi* 1 , Martin Cortina 2 , Betina Orman 3
1Centro de Investigación Avanzada para la Presbicia,Private,Buenos Aires,Argentina;Universidad de Buenos Aires. Facultad de Odontología. Cátedra de Farmacología,Universidad de Buenos Aires,Buenos Aires,Argentina, 2Instituto Oftalmológico Cortina,Private,Santa Rosa, La Pampa,Argentina, 3Universidad de Buenos Aires. Facultad de Odontología. Cátedra de Farmacología,Universidad de Buenos Aires,Buenos Aires,Argentina
Purpose
To evaluate the long-term efficacy of the hyperopic LASIK performed in combination with the pharmacological treatment of presbyopia Benozzi Method in presbyopic population.
Setting
Pharmacological treatment of presbyopia with Benozzi Method is an effective option to enhance and stabilize hyperopic LASIK surgery visual results across time.
Methods
A non-randomized case-series was settled, including presbyopic patients who were pharmacologically treated with Benozzi Method after bilateral hyperopic LASIK surgery was performed, with 2 years of follow-up, at two private ophthalmological clinics of Argentina. Main outcomes assessed were spherical equivalent (SE), uncorrected distance visual acuity (UDVA) and uncorrected near visual acuity (UNVA).
Measurements were evaluated at baseline, postoperative at 1 month (without Benozzi Method), 2 months after surgery starting with Benozzi Method, and 2 years after surgery and pharmacological treatment of presbyopia. The SE stability through time was statistically evaluated.
Results
84 eyes of 42 patients were included in this study with 2 years of follow-up and a mean age at the time of the surgery of 51.07± 4.5 (42-59 years old). Patients have achieved Jaeger 1 in the second month after LASIK surgery and Benozzi Method was administered, which was preserved up to the last year of follow-up. UDVA was improved and maintained in all cases. Refractive stability through time is observed comparing first month after surgery with the last year of follow-up, without statistically significant difference (p: 0.11).
Conclusions
Hyperopic presbyopic patients achieved an excellent UNVA and UDVA, both stable over time without refractive regression after LASIK surgery in combination with the pharmacological treatment of presbyopia (Benozzi Method) 1 month later.